Structure and form of release
Structure
1 tablet contains
:
Active ingredients: 250 mg of sodium of alginate, 106.5 mg of Natrii hydrocarbonas, 187.5 mg of calcium of a carbonate;
Excipients: the macrogoal 20000, attracts (E 421), kopolividon, potassium to atsesulfa, aspartame (E 951), mint J8696 fragrance, karmoizin (E 122), magnesium stearate, xylitol DC.
release Form
chewable tablets.
Pharmacological properties
Pharmacodynamics. Medicine is a combination of two antacids (calcium carbonate, hydrosodium carbonate) and sodium alginate which has the adsorbing and enveloping effect. after reception, medicament quickly reacts with gastric acid, forming a layer of gel of alginic acid which has almost neutral value rn and covers stomach walls, effectively preventing emergence of a gastroesophageal reflux. in hard cases the gel layer distributed on a stomach contents surface rises in a gullet and prevents his irritation.
Calcium carbonate neutralizes gastric acid and provides fast simplification in digestive disturbances and heartburn. This effect amplifies thanks to hydrosodium carbonate which also has neutralized effect. The general neutralized ability of a product at the minimum dose of 10 ml is about 10 mekv H + .
Pharmacokinetics. The mechanism of effect of medicine — physical also does not depend on absorption in a system blood stream.
Indication
Treatment of the symptoms of a gastroesophageal reflux connected with acidity of contents of a stomach which is thrown in a gullet, such as acid eructation, heartburn, digestive disturbance, for example, after meal or during pregnancy.
Contraindication
Hypersensitivity (allergy) to any component of drug.
Use Medicine is intended toby
for oral administration.
Gaviskon of Dual action, tablet. Tablets should be chewed carefully. Adults and children are aged more senior than 12 years: on 2–4 tablets after a meal and before going to bed, up to only 4 times a day.
Patients of advanced age: for this age group of dose adjustment it is not required.
Gaviskon of Dual action, suspension. To adults and children 12 years are aged more senior — on 10–20 ml (2–4 teaspoons) after a meal and before going to bed, up to 4 times a day. Before use to shake up. It is not necessary to adjust a dose for patients of advanced age.
Special instructions
Each 4 tablets of medicament contain 221.5 mg (9.64 mmol) of sodium, and each 10 ml of suspension — 127.25 mg (5.53 mmol) of sodium. it should be considered to patients who adhere to a diet with high restriction of salt, for example, in certain cases of stagnant heart failure and a renal failure.
Each 4 tablets contain 300 mg (7.5 mmol) of calcium, and each 10 ml of suspension — 130 mg (3.25 mmol) of calcium. The medicament should be taken carefully to patients with a hypercalcemia, a nephrocalcinosis and recurrent formation of nephroliths, calciferous.
Gaviskon Dual action contains aspartame which is a phenylalanine source. Therefore means can constitute danger to patients with phenylketonuria.
Gaviskon Dual action, tablets contain karmoizin (E 122) which can cause allergic reactions.
Gaviskon of Dual action, suspension contains methylparahydroxybenzoate (E 218) and propilparagidroksibenzoat (E 216) which can cause the allergic reactions which are (perhaps delayed).
Gaviskon Dual action, tablets contains xylitol which can have laxative effect. Energy value of 1 g of xylitol — 2.4 kcal.
in case of lack of reduction of expressiveness of symptomatology in 7 days of treatment the clinical situation demands revision.
Use during pregnancy and feeding by a breast
Gaviskon of Dual action does not influence a pregnancy course, pre-natal and post-natal development of the child. Drug can be used during pregnancy and feeding by a breast.
to Drivers
Drug does not affect ability to run vehicles and to work with mechanisms.
Children. It is not recommended to apply at children aged up to 12 years.
Overdose
Overdose happens very seldom and can be shown by discomfort and feeling of swelling in a stomach.
At overdose needs to stop use of medicament and to carry out symptomatic therapy.
Side effects
Very seldom (1/10,000) patients with hypersensitivity to components of medicament can have an allergic reaction in the form of a small tortoiseshell, a bronchospasm, anaphylactic or anaphylactoid reactions.
Reception of a large amount of calcium of a carbonate can leadto development of an alkalosis, a hypercalcemia, acid ricochet, milk and alkaline syndrome or a constipation. As a rule, such symptoms arise owing to exceeding the recommended dose.
Interaction
Due to presence of calcium carbonate which works as an antacid needs to maintain a 2-hour interval between administration of medicament gaviskon dual action and other medicines, especially blockers of n2-histamine receptors, tetracyclines, digoxin, ftorkhinolony, iron salts, ketakonazoly, neuroleptics, thyroxine, Penicillaminum, blockers of β-adrenoceptors (atenolol, metoprolol, propranolol), gks, chloroquine and diphosphonates.
Storage conditions
In original packing at a temperature not above 30 °C. not to store suspension in the fridge and not to freeze.
Characteristics | |
Active ingredients | Calcium carbonate, Sodium alginate, Natrii hydrocarbonas |
Amount of active ingredient | 250 mg + 133.5 mg + 80 mg |
Applicant | Rekkitt Benkizer |
Code of automatic telephone exchange | A02BX Other drugs for treatment of a round ulcer and a gastroesophageal reflux disease |
Interaction with food | Later |
Light sensitivity | Not sensitive |
Market status | Traditional |
Origin | Chemical |
Prescription status | Without prescription |
Primary packing | blister |
Producer | REKKITT BENKIZER HELSKER INTERNATIONAL LIMITED |
Quantity in packing | 24 tablets (3 blisters on 8 pieces) |
Release form | tablets for internal use |
Route of administration | Oral |
Sign | Import |
Storage temperature | from 15 °C to 25 °C |
Trade name | Gaviskon |
Gaviskon of dual action of the tab. zhev. No. 24
- Product Code: 180770
- In Stock
- Ready to ship
-
$23.16